Major Objectives of this Study:

# To define, describe, segment, and forecast the global reporter gene assay market by product, application, end user, and region.

# To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of the market in five main regions (along with major countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

# To profile key players in the global market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global reporter gene assays market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20053198

Expected Revenue Growth:

The reporter gene assays market is projected to reach USD 2.6 billion by 2024 from USD 1.6 billion in 2019, at a CAGR of 10.1%. Factors contributing to the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and rising preference for cell-based assays.

Recent Developments in Global Market:

# In 2018, Thermo Fisher acquired Advanced Bioprocessing business from BD, to expand Thermo Fisher Scientific’s cell-culture media products and strong technical services program

# In 2017, Becton, Dickinson and Company acquired C.R Bard (US). This acquisition advanced BD’s product offerings and global reach.

# In 2018, Merck opened a new 3,800-square-meter laboratory in Singapore.

# In 2018, Thermo Fisher Scientific (US) opened its Bioprocess design center in Shanghai.

By application, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period (2019-2024)”

Based on application, the reporter gene assay market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. In 2019, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to its importance in several cellular functionalities (such as cell differentiation, cell fate determination, and cell growth) and advanced applications of cell signaling in life science sectors (such as biotechnology, molecular biology, and microbiology).

Critical Questions the Report Answers:

# Where will all these developments take the industry in the mid-to-long term?

# What are the major end users of reporter gene assays?

# What are the application areas of the reporter gene assays?

# Which are the most commonly used reporter gene assays kits?

# What is the global scenario of the reporter gene assay market?

Geographical Growth Survey:

North America to hold the largest regional market share in 2019

North America is expected to account for the largest share of the reporter gene assays market in 2019, followed by Europe. The large share of North America in the global market can be attributed to the growing academic and government investments in genomics and proteomics research; rising demand for cell-based assays in research; increasing focus on cell-based therapeutics; and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=20053198

Key Players:

The prominent players in the reporter gene assay market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]